MORPHOMETRIC ANALYSIS OF MICROGLIA IN ALZHEIMERS-DISEASE

被引:85
作者
CARPENTER, AF
CARPENTER, PW
MARKESBERY, WR
机构
[1] UNIV KENTUCKY,MED CTR,DEPT PATHOL,101 SANDERS BROWN BLDG,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,MED CTR,DEPT NEUROL,LEXINGTON,KY 40536
[3] UNIV KENTUCKY,MED CTR,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536
关键词
ALZHEIMERS DISEASE; COMPUTERIZED MORPHOMETRIC IMAGE ANALYSIS; LN3; IMMUNOCYTOCHEMISTRY; MICROGLIA;
D O I
10.1097/00005072-199311000-00007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
HLA-DR-immunoreactive microglia were quantitated in the middle temporal gyrus of five late-stage patients with Alzheimer's disease (AD) and five age-matched control subjects using LN3 immunocytochemistry and computerized morphometric image analysis. The grand mean numerical density of HLA-DR-immunoreactive microglia in AD (403.86/mm2) was significantly larger than in the five control subjects (193.33/mm2) (p < 0.000 1). The grand mean cross-sectional area of HLA-DR-immunoreactive microglia in AD subjects (222.90 mum2) was significantly larger than in control subjects (121.59 mum2) (p < 0.0001). The percentage of total microglia that were large activated microglia was much greater in AD (47.9%) than in control subjects (15.2%). The grand mean percent of the cortical area occupied by HLA-DR-immunoreactive microglia in AD (9.02%) was significantly greater than in controls (2.35%) (p < 0.0001). Microglia were present in greater numbers in the outer three cortical laminae in both AD and controls. The striking increase in activated microglia in the neocortex and their role in the inflammatory response and possible secretion of neurotoxins could be important in neuron degeneration in AD.
引用
收藏
页码:601 / 608
页数:8
相关论文
共 50 条
  • [41] THE EEG SPECTRA OF ALZHEIMERS-DISEASE
    GIANNITRAPANI, D
    COLLINS, J
    VASSILIADIS, D
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1991, 10 (03) : 259 - 269
  • [42] PATHOGENETIC FACTORS OF ALZHEIMERS-DISEASE
    BAUER, J
    HULL, M
    BERGER, M
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1995, 28 (03): : 155 - 162
  • [43] DETERMINANTS OF DISABILITY IN ALZHEIMERS-DISEASE
    ZANETTI, O
    BIANCHETTI, A
    FRISONI, GB
    ROZZINI, R
    TRABUCCHI, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1993, 8 (07) : 581 - 586
  • [44] THE ACOUSTIC CORTEX IN ALZHEIMERS-DISEASE
    BALOYANNIS, SJ
    MANOLIDIS, SL
    MANOLIDIS, LS
    ACTA OTO-LARYNGOLOGICA, 1992, : 1 - 13
  • [45] MOLECULAR NEUROPATHOLOGY OF ALZHEIMERS-DISEASE
    MASTERS, CL
    BEYREUTHER, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (3A): : 410 - 412
  • [46] PERIPHERAL SEROTONIN IN ALZHEIMERS-DISEASE
    KUMAR, AM
    SEVUSH, S
    KUMAR, M
    RUIZ, J
    EISDORFER, C
    NEUROPSYCHOBIOLOGY, 1995, 32 (01) : 9 - 12
  • [47] ALUMINUM AND THE RISK FOR ALZHEIMERS-DISEASE
    MCLACHLAN, DRC
    ENVIRONMETRICS, 1995, 6 (03) : 233 - 275
  • [48] ALZHEIMERS-DISEASE - A PISCATORIAL TREK
    VANEERDEWEGH, P
    HAMPE, CL
    SUAREZ, BK
    REICH, T
    GENETIC EPIDEMIOLOGY, 1993, 10 (06) : 395 - 400
  • [49] PSYCHOTIC SYMPTOMS IN ALZHEIMERS-DISEASE
    JABEEN, S
    MCKEITH, IG
    FAIRBAIRN, AF
    PERRY, RH
    FERRIER, IN
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, 7 (05) : 341 - 345
  • [50] SERUM AUTOANTIBODIES IN ALZHEIMERS-DISEASE
    LOPEZ, OL
    RABIN, BS
    HUFF, FJ
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (05): : 441 - 444